Abstract: The present invention provides biomarker of antipsychotic treatment response in patients with schizophrenia and other disorders involving DRD2 and methods for using the same.
Type:
Application
Filed:
October 1, 2010
Publication date:
August 16, 2012
Applicant:
THE REGENTSN OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Inventors:
Judith Morse Gault, Ann Olincy, Robert House, Bifeng Gao